We analyzed the expression patterns of ghrelin in the hypothalamus, the specific neuronal sites of ghrelin binding, and its electrophysiological effects on circuits previously shown to be leptin responsive. We investigated the complex actions upon neuropeptide circuits that regulate feeding and metabolism to establish an integrated concept of the role of central ghrelin in the regulation of energy homeostasis.
Results

Expression of Ghrelin in the Brain
Early studies of ghrelin mRNA distribution demonstrated expression in the brain (Kojima et al., 1999), and our RT-PCR analysis of rat stomach and hypothalamus RNA showed a 320 bp product ( Figure 1A , top). This product was then sequenced and found to correspond perfectly (data not shown) with the published ghrelin sequence (Kojima et al., 1999). In further support of ghrelin production in the brain, no ghrelin mRNA was detected in the hypothalamus of ghrelin knockout mice, while their wildtype littermates showed similar expression pattern as described for the rat (data not shown).
Next, we analyzed the existence of ghrelin protein in the hypothalamus using three antisera, which had been of RT, 10 l of PCR product loaded onto the gel) compared to the stomach (50 ng of RT, 5 l of PCR product loaded onto the gel). Western blot analyses show (bottom) that the antibody labels a band around 13 kDa that corresponds to the size of pro-ghrelin. Figure 1 . Ghrelin mRNA and Peptide Expression in the HypoNote that 100 g of hypothalamic protein (Hyp) was loaded while thalamus for the stomach 30 g was loaded. The ghrelin level in the stomach (A) Ghrelin expression in the rat stomach and hypothalamus. PCR is several fold higher than in the total hypothalamus. products (top) were separated on a 1.5% agarose gel stained with (B) Schematic illustration of ghrelin-immunoreactive cell bodies (red) ethidium bromide. It should be noted that approximately four times and projections (red dots) within the hypothalamus and adjacent the material was loaded onto the gel for the hypothalamus (100 ng areas at different distances from Bregma. independently generated against ghrelin. In Western ghrelin in the hypothalamus and stomach ( Figure 2D ) using these antisera. In colchicine-treated animals, the blots, these antisera labeled a band that corresponds to the nonsecreted ghrelin prohormone (13 kDa) (Figure intensity and number of labeled cells in this area was enhanced, which is a characteristic feature of several 1A, bottom), confirming that ghrelin is produced in the hypothalamus.
hypothalamic peptidergic systems. Ghrelin-immunoreactive neurons had a mostly bipolar shape and freGhrelin-immunoreactive cell bodies were detected in the hypothalamus of rats and mice and were distributed quently exhibited rectangular appearance ( Figure 2C Figure 3D ). mus, including the bed nucleus of stria terminalis, medial, central, and cortical amygdale, the thalamic paraBiotinylated ghrelin binding was specific, since it was prevented by pretreatment with an excess of unlabeled ventricular nucleus, and lateral habenula (Table 1) neurons, ghrelin (50-100 nM) treatment was observed to increase the frequency of spontaneous GABAergic Ghrelin (50 nM) increased the activity of NPY neurons 3.7-fold within 4 min ( Figure 4B ; n ϭ 9); this increased inhibitory postsynaptic currents (IPSCs) onto POMC neurons (by up to 300%, mean ϭ 149% Ϯ 14%; n ϭ 18; activity was reversible with washout. This finding showed that ghrelin was likely increasing the release of p Ͻ 0.006; Figure 4C ). These IPSCs were previously shown to be due to GABA secretion from NPY neurons NPY and AGRP at targets of arcuate NPY/AGRP neurons. Coincident with its effect on the spontaneous ac- Figure 4D ; n ϭ 6) and a small, but significant, hyperpowe were not able to identify the specific ion conductance that was modified by ghrelin, probably because of poor larization ( Figure 4E ; range 0.4 to 13 mV, mean 1.47 Ϯ 0.7 mV; p Ͻ 0.03, n ϭ 34), consequently decreasing the voltage clamp in the slice preparation.
(H), and (J). (B-E) Ghrelin binding is associated with axon terminals in the ARC (B), LH (C), cortex (D), and PVH (E). Arrowheads in (B), (C), and (E) point to labeled boutons. Scale bar in (C) represents 10 m for (B), (C), and (E)-(G). Scale bar in (D) represents 10 m for (D), (I), and (K). (F and G) Axon terminals that bound labeled ghrelin (F, red fluorescence; green arrowheads point to some of the labeled presynaptic terminals) were frequently immunopositive for NPY (G, green fluorescence; red arrowheads point to those NPY-immunolabeled boutons that are indicated with green arrows in F). (H-J) Biotinylated ghrelin binding (H and I) is abolished when coincubated with unlabaled ghrelin (J and K). (I) and (K) are high-magnification views of (H) and (J)
We examined the effect of ghrelin on POMC neurons frequency of action potentials in these neurons. Blockade of GABA A receptors (picrotoxin 100 M) did using hypothalamic slices from mice expressing green NPY and POMC neurons. In conventional and perforated sis that ghrelin action in the PVH results from NPY release. In the ghrelin-responsive neuron of Figure 5A , patch whole-cell recordings the GABAergic inputs to 73% of medial PVH neurons was inhibited (28% Ϯ 1.5%) preapplication of a cocktail of NPY Y 1 and Y 5 antagonists (BIBO 3304, 500 nM; Novartis 2, 500 nM, respectively) by ghrelin ( Figure 5A ), while 27% of cells showed no effect of ghrelin. We have previously shown that NPY substantially reduced or blocked the effect of ghrelin ( Figure 5B ). In 5 of 11 ghrelin-sensitive neurons tested, exerts an identical effect on these neurons, which results from a presynaptic reduction of GABA release rather this antagonist cocktail reduced the ghrelin effect by 59% Ϯ 12% (n ϭ 5, p Ͻ 0.005; Figure 5C ). Interestingly, while ghrelin immunolabeling was mainly present in the hypothalamus, ghrelin binding was also present in extrahypothalamic sites, including the IPSC response to ghrelin in a PVH neuron; Figure 5E cerebral cortex, raising the possibility that either periphshows the response to NPY in the same neuron. The erally circulating ghrelin can cross the blood-brain barmagnitude and time course of the response to ghrelin rier to reach these cortical sites, or that additional en-(30-100 nM; n ϭ 16) and to NPY (100-300 nM) applied dogenous ligands exist for the GHS-R and/or that ghrelin to ghrelin-sensitive neurons (n ϭ 9) is shown in Figure  may have affinity to receptors other than the currently 5F. Thus, NPY and ghrelin act on the inputs to the same known GHS-Rs. PVH neurons in the same manner.
To identify the neuropeptide phenotype of neurons that showed a ghrelin-sensitive IPSC, we filled PVH neu-
Physiology of Ghrelin's Effect
The extensive apposition between terminals of hyporons (n ϭ 20) with biocytin at the conclusion of a perforated patch electrophysiological recording and tested for thalamic neurons and ghrelin-expressing boutons suggested a presynaptic mode of action of ghrelin in the colocalization of the intracellular marker with CRH and thyrotropin-releasing hormone (TRH) immunoreactivity.
hypothalamus. Both the binding data and the expression of ghrelin in axons adjacent to presynaptic nerve termiEight of twenty mpPVH neurons we analyzed expressed CRH, and seven of these neurons showed a decreased nals suggested that ghrelin may exert modulatory effects on neurotransmission. The dependence of ghrelin IPSC in response to ghrelin (Figures 6A and 6B) containing 0.1% sodium borohydride and 50 mM glycine; (6) 10 min Western blot analyses were also carried out with these antisera in TBST ϩ 2% BSA; (7) incubation for 1-2 hr in rabbit anti-ghrelin on intact rat hypothalamic and stomach homogenates. The antisera diluted 1:1000 in TBST ϩ 2% BSA; (8) 2 ϫ 10 min wash in TBST; allowed the visualization of a band at 13 kDa, corresponding to the 10 min rinse in TBST ϩ 2% BSA; (9) 2 hr incubation in gold-conjugated estimated size of pro-ghrelin. Immunolabeling with these antisera (25 nm) anti-rabbit IgG diluted 1:20 in the same buffer; (10) 3 ϫ 3 min in 1:200-1:2000 dilutions using the avidin-biotin-peroxidase method wash in DDW. Sections were then further immunostained for GABA. and diaminobenzidine as chromogen resulted in specific labeling
The same steps were taken as for the ghrelin immunolabeling, exin hypothalamic sites that was abolished by preadsorption of the cept that antisera against GABA was used (guinea-pig anti-GABA; antisera with ghrelin. Furthermore, all the antisera displayed identi-1:1000) and the secondary antisera was 10 nm gold-conjugated cal patterns of immunolabeling of rat hypothalamus. Data reported anti-guinea pig IgG. Sections were then contrasted with saturated uranyl acetate (10 min) and lead citrate (20-30 s). Ultrathin sections are from paraformaldehyde (4%) or acrolein (2%)-fixed rat tissue;
